We are live on ! Find out more
DCM

Defilade Capital Management Portfolio holdings

AUM $747M
This Fund
S&P 500
This Quarter Est. Return
+36.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$738M
AUM Growth
–
Cap. Flow
+$677M
Cap. Flow %
91.82%
Top 10 Hldgs %
55.1%
Holding
33
New
33
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$55.6M
2
ABBV icon
AbbVie
ABBV
+$51.9M
3
NVS icon
Novartis
NVS
+$47.5M
4
ICUI icon
ICU Medical
ICUI
+$45.6M
5
STE icon
Steris
STE
+$34M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXST icon
26
RxSight
RXST
$265M
$9.51M 1.29%
+913,090
New +$9.16M
ELAN icon
27
Elanco Animal Health
ELAN
$12.5B
$9.08M 1.23%
+401,283
New +$8.73M
INSM icon
28
Insmed
INSM
$27.2B
$8.7M 1.18%
+50,000
New +$9.12M
OCUL icon
29
Ocular Therapeutix
OCUL
$2.37B
$8.28M 1.12%
+681,663
New +$8.28M
TFX icon
30
Teleflex
TFX
$5.88B
$5.23M 0.71%
+42,850
New +$5.19M
ELDN icon
31
Eledon Pharmaceuticals
ELDN
$272M
$4.97M 0.67%
+3,290,450
New +$7.82M
CNMD icon
32
CONMED
CNMD
$1.51B
$4.23M 0.57%
+104,129
New +$4.53M
EVMN
33
Evommune Inc
EVMN
$512M
$3.69M 0.5%
+215,418
New +$4.05M
1
2

Similar funds

BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
PCM
Permanent Capital Management Chicago, Illinois $747M AUM 17.94% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $748M AUM 27.21% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $745M AUM 23.99% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $745M AUM 27.52% 1-Year Est. Return
VCM
Virtue Capital Management Brentwood, Tennessee $749M AUM 40.13% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $745M AUM 25.89% 1-Year Est. Return
CCME
CIBC Capital Markets (Europe) Luxembourg $745M AUM

Defilade Capital Management's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for Defilade Capital Management, which disclosed 33 positions worth $738M. Its ten largest holdings account for 55% of the portfolio.

Its largest position is Pfizer: 2,203,504 shares worth $54.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Defilade Capital Management's largest Q4 2025 buy was Pfizer: 2,203,504 shares worth $54.9M.
  • Defilade Capital Management's ten largest holdings make up 55% of its $738M portfolio in Q4 2025.
  • Defilade Capital Management disclosed 33 positions in Q4 2025, its first 13F filing on record.

Based on Defilade Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.